Share: Facebook Twitter GooglePLus LinkedIn
Activity Provided By:


Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Access Activity

Overview / Abstract:

Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of death and mortality in the United States, and elevated serum low-density lipoprotein cholesterol (LDL-C) is a widely-recognized risk factor. Because most initial presentations of symptoms of heart disease are referred to interventional cardiologists, these clinicians play a central role in managing patients with clinical ASCVD and preventing recurrence of major adverse cardiac events. Since hypercholesterolemia is a major driver of ASCVD, lipid-lowering therapies (mainly in combination with statins) are the primary treatment approach to lower LDL-C and reduce CVD risk.

The CME activity, The Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice, will help interventional cardiologists and other members of the cardiac care team ensure that ASCVD patients receive optimal lipid-lowering therapy to reduce the risk of recurrent events. Modules within the activity will allow participants to explore current guideline recommendations and clinical-trial results, review new and emerging treatment options, and discuss the benefits and limitations of those therapies.

EDUCATIONAL OBJECTIVES - At the conclusion of this activity, participants should be able to demonstrate the ability to:

- Identify residual CVD risk in high-risk patients and address additional CVD risk elements as appropriate
- Differentiate the clinical properties of new and emerging pharmacologic approaches to reduce LDL-C and lower CVD risk
- Analyze the potential strengths and weaknesses of new approaches to reduce CVD risk with new LDL-C -lowering agents in combination with statins


Sep 15, 2019


Physician CME


Online, Webinar / Webcast / Video

Credits / Hours

AACME - 1.25 AMA PRA Category 1 Credit(s)™; 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program


Jointly provided by Potomac Center for Medical Education and Rockpointe

Presenters / Authors / Faculty

Executive Director of Interventional Cardiovascular Programs
Brigham and Women's Hospital Heart and Vascular Center
Professor of Medicine
Harvard Medical School
Boston, MA

Lipidology and Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School and NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association
New York, NY

Sponsors / Supporters / Grant Providers

This program is supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

Keywords / Search Terms

Rockpointe Atherosclerotic cardiovascular disease, ASCVD, LDL-C, Lipids, CME, Free CME, Continuing Medical Education, CME Webcourse, Primary Care, Primary Care Provider, On-Demand CME, Cardiologists, Cardiology, Cardiovascular Disease Free CE CME

Access Activity

RXinsider,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps. RXinsider,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the Terms of Service. Site Map.